Piper Sandler maintained its Overweight rating on Five9 (NASDAQ: FIVN) but slashed the price target to $35 from $47, ...

As you can see from the chart above the percentage of shares that are sold short for Piper Sandler has grown since its last report. This does not mean that the stock is going to fall in the near ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

JMP Securities analyst Devin Ryan maintained a Hold rating on Piper Sandler (PIPR – Research Report) today. The company’s shares closed yesterday at $271.44. According to TipRanks, Ryan is a ...

Investing.com -- Piper Sandler initiated coverage on Abbott Laboratories (NYSE:ABT) with an "overweight" rating and a price target of $131 per share. Piper Sandler emphasizes Abbott’s ...

Piper Sandler kept its Overweight rating on Five9 ( NASDAQ: FIVN) but reduced the price target to $35 from $47. Last month, Five9 said it was planning to reduce its global workforce by 7% as part of ...

Piper Sandler analyst Adam Maeder maintained a Hold rating on Axonics Modulation Technologies (AXNX – Research Report) today and set a price target of $71.00. The company’s shares closed ...

MINNEAPOLIS, September 16, 2024--(BUSINESS WIRE)--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of Steve Tipler as a managing director in the ...

Raymond James, which downgraded the stock to market ... It likewise lowered its price target to $14 from $37. Piper Sandler, meanwhile, cut its rating to neutral, citing the potential of an ...

MINNEAPOLIS, September 09, 2024--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the additions of Joe Kinder and Brent Blevins as managing directors to its ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...